[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents.
ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …
Immunotherapy: building a bridge to a cure for type 1 diabetes
JA Bluestone, JH Buckner, KC Herold - Science, 2021 - science.org
Type 1 diabetes (T1D) is an autoimmune disease in which T cells attack and destroy the
insulin-producing β cells in the pancreatic islets. Genetic and environmental factors increase …
insulin-producing β cells in the pancreatic islets. Genetic and environmental factors increase …
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals
EK Sims, BN Bundy, K Stier, E Serti, N Lim… - Science translational …, 2021 - science.org
We analyzed the effects of a single 14-day course of teplizumab treatment on metabolic
function and immune cells among participants in a previously reported randomized …
function and immune cells among participants in a previously reported randomized …
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
KC Herold, BN Bundy, SA Long… - … England Journal of …, 2019 - Mass Medical Soc
Background Type 1 diabetes is a chronic autoimmune disease that leads to destruction of
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …
insulin-producing beta cells and dependence on exogenous insulin for survival. Some …
New frontiers in the treatment of type 1 diabetes
JT Warshauer, JA Bluestone, MS Anderson - Cell metabolism, 2020 - cell.com
Type 1 diabetes is an autoimmune disease caused by the immune-mediated destruction of
pancreatic β cells that results in lifelong absolute insulin deficiency. For nearly a century …
pancreatic β cells that results in lifelong absolute insulin deficiency. For nearly a century …
Current and future therapies for type 1 diabetes
BJ von Scholten, FF Kreiner, SCL Gough… - Diabetologia, 2021 - Springer
In type 1 diabetes, insulin remains the mature therapeutic cornerstone; yet, the increasing
number of individuals developing type 1 diabetes (predominantly children and adolescents) …
number of individuals developing type 1 diabetes (predominantly children and adolescents) …
Diabetes: advances in diagnosis and treatment
DM Nathan - Jama, 2015 - jamanetwork.com
Importance Chronic diseases have overtaken acute diseases, such as infections, as the
major cause of premature mortality worldwide. Diabetes mellitus, a chronic degenerative …
major cause of premature mortality worldwide. Diabetes mellitus, a chronic degenerative …
Heterogeneity and endotypes in type 1 diabetes mellitus
MJ Redondo, NG Morgan - Nature Reviews Endocrinology, 2023 - nature.com
Despite major advances over the past decade, prevention and treatment of type 1 diabetes
mellitus (T1DM) remain suboptimal, with large and unexplained variations in individual …
mellitus (T1DM) remain suboptimal, with large and unexplained variations in individual …
Stem cell therapies for treating diabetes: progress and remaining challenges
Restoration of insulin independence and normoglycemia has been the overarching goal in
diabetes research and therapy. While whole-organ and islet transplantation have become …
diabetes research and therapy. While whole-organ and islet transplantation have become …
Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation
S Hummel, J Carl, N Friedl, C Winkler, K Kick, J Stock… - Diabetologia, 2023 - Springer
Aims/hypothesis We aimed to determine whether disease severity was reduced at onset of
clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type …
clinical (stage 3) type 1 diabetes in children previously diagnosed with presymptomatic type …